Lymphoma
Cutaneous T-Cell:
IRB # H-24290: UVADEX (Methoxsalen) sterile solution in conjunction wuith the UVAR XTS Photopheresis System as an Interventional Therapy for the treatment of CTCL (Mycosis Fungoides) in Patients with TMN classification stage IA, IB, IIA. (contact Marsha.Stevens@bmc.org)
BioCryst / WIRB #2007-1017: Single Agent Phase II Study of Forodesine (BCX1777) in the Treatment of Cutaneous T-Cell Lymphoma
Hodgkin’s Lymphoma:
IRB #H-29038/SWOG #S0816: A Phase II Trial of Response Adapted Therapy of Stage III-lV Hodgkin Lymphoma Using Early Interim FDG-PET Imaging (pending)
Peripheral T-Cell:
TopoTarget/ WIRB #2008-2112: A Multicenter, Open-Label Trial of Belinostat in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma
Lymphoid Malignancies:
IRB #H-27642: A Phase II Trial of Low-Dose Arginine Butyrate and Ganciclovir/Valganciclovir in EBV (+) Lymphoid Malignancies (pending)
IRB #H-26640: Telomere DNA-Based experimental Analysis of Lymphoid Malignancy (Contact G.Denis @ 4-1371)
